FBN1 and Marfan syndrome: Mouse models of Marfan syndrome have demonstrated increased TGF-β/Smad signaling in myxomatous valve pathophysiology, consistent with a role for FBN1 in limiting TGF-β activity in the extracellular matrix (7–9).